World's Best Scientists 2026 revealed!
Expert Opinion on Pharmacotherapy
H-index 30

Expert Opinion on Pharmacotherapy

1465-6566

Published by: Taylor & Francis

https://www.tandfonline.com/toc/ieop20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 808 250 340 26

Additional Metrics

Number of Best Scientists*: 356
Documents by Best Scientists*: 448
Top 100 Ranked Scientists*: 6
SCIMAGO H-index: 99
SCIMAGO SJR: 0.672
Impact Factor: 2.7

Overview

Top Research Topics at Expert Opinion on Pharmacotherapy?

The journal primarily tackles Internal medicine, Intensive care medicine, Pharmacology, Pharmacotherapy and Clinical trial. The majority of Internal medicine studies presented zero in on Disease. It focuses on Intensive care medicine but the discussions also offer insight into other areas such as Anesthesia, Surgery, MEDLINE, Immunology and Physical therapy.

Pharmacology studies presented in the journal focus on topics such as Drug, Adverse effect, Tolerability and Pharmacokinetics. It focused on Pharmacotherapy research conducted under the discipline of Psychiatry. While work presented in the journal provided substantial information on Oncology, it also covered topics in Cancer, Breast cancer and Chemotherapy.

The Cardiology research dealing mostly with Myocardial infarction is the focus of the journal. It covers various topics on Endocrinology such as Diabetes mellitus and Type 2 diabetes.

  • Internal medicine (37.97%)
  • Intensive care medicine (22.30%)
  • Pharmacology (17.76%)

What are the most cited papers published in the journal?

  • Albumin-bound paclitaxel: a next-generation taxane (462 citations)
  • Toxicity of platinum compounds (385 citations)
  • Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression. (306 citations)

Research areas of the most cited articles at Expert Opinion on Pharmacotherapy:

The most cited publications cover a variety of subjects, including Internal medicine, Pharmacology, Intensive care medicine, Pharmacotherapy and Clinical trial. While Internal medicine is the key highlight in the journal publications, thet also covered some subjects on Oncology and Breast cancer and Cancer. The most cited publications explore research in Intensive care medicine alongside concepts in Disease and other areas of study in Immunology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Cancer

The previous edition focused in particular on these issues:

The journal is mainly concerned with subjects like Internal medicine, Intensive care medicine, Pharmacotherapy, Disease and Clinical trial. The journal explores topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology, Diabetes mellitus and Oncology. In Expert Opinion on Pharmacotherapy, Targeted therapy, Prostate cancer and Immunotherapy are investigated in conjunction with one another to address concerns in Oncology research.

The study of Intensive care medicine encompasses disciplines such as Type 2 diabetes, as well as fields such as Metformin, all of which overlap with one another. The Pharmacotherapy study featured falls within the wider field of Psychiatry. The Clinical trial study featured in the journal draws parallels with the field of Tolerability.

The most cited articles from the last journal are:

  • An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection (8 citations)
  • Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective. (7 citations)
  • State-of-the-art pharmacotherapy for diabetic neuropathy. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Expert Opinion on Pharmacotherapy (based on the number of publications) are:

  • Sheila A Doggrell (117 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Dimitri P. Mikhailidis (34 papers) absent at the last edition,
  • Sabina A Antoniu (25 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Gregory Y.H. Lip (22 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Steven R. Feldman (20 papers) published 4 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Opinion on Pharmacotherapy (based on the number of publications) are:

  • Sapienza University of Rome (60 papers) published 4 papers at the last edition, 4 less than at the previous edition,
  • Mayo Clinic (54 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Duke University (52 papers) absent at the last edition,
  • University of Genoa (49 papers) published 6 papers at the last edition, 2 less than at the previous edition,
  • University College London (48 papers) published 2 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.72% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.18% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.73% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.03% of all publications and 61.06% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Pathways Inspired by Expert Opinion on Pharmacotherapy

For those aspiring to make substantial contributions in the field of Pharmacotherapy research, the Expert Opinion on Pharmacotherapy journal can serve as an excellent source of inspiration and guidance. This esteemed journal features work by renowned experts in the field, addressing pressing topics such as Disease, Oncology, Immunology, and more. It offers comprehensive insights into the innovative approaches and methodologies adopted by these scholars.

As you navigate your journey from student to professional, understanding the paths taken by the experts whose work is showcased in Expert Opinion on Pharmacotherapy can be beneficial. For instance, if you're interested in the cross-section of Psychiatry and Pharmacotherapy, studying articles from the discipline of Psychiatry, could offer a profound understanding of the field and inspire your future research endeavors.

Furthermore, aspiring researchers may be curious about the specific pathways these experts took to their respective fields. Thus, it's worth exploring career guide articles, such as how to become a nurse practitioner in Florida, as a point of reference to understand the educational and experiential paths available. By reviewing such resources, readers can gain a broader perspective of the possible career trajectories and make informed decisions about their education and career planning.

In conclusion, the Expert Opinion on Pharmacotherapy journal does not only serve as a platform for presenting high-quality research, but it also acts as a stimulator, inspiring budding pharmacotherapists to contribute profoundly to the medical world.

Top Publications

  • Pharmacotherapy for knee osteoarthritis: current and emerging therapies.

    Peihua Cao;Yamin Li;Yujin Tang;Changhai Ding;Changhai Ding

    (2020)
    67 Citations
  • Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention.

    Hennie G Raterman;Irene Em Bultink;Willem F Lems

    (2020)
    58 Citations
  • Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

    Joanna Kryst;Paweł Kawalec;Paweł Kawalec;Andrzej Pilc;Andrzej Pilc

    (2020)
    58 Citations
  • Selinexor for the treatment of multiple myeloma.

    Klaus Podar;Jatin Shah;Ajai Chari;Paul G Richardson

    (2020)
    56 Citations
  • Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors

    Giovanna Garufi;Giovanna Garufi;Antonella Palazzo;Ida Paris;Armando Orlandi

    (2020)
    53 Citations
  • Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction.

    Amit Rout;Udaya S Tantry;Marko Novakovic;Ajaypaul Sukhi

    (2020)
    50 Citations
  • Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis.

    Joeri Lambrecht;Leo A van Grunsven;Frank Tacke

    (2020)
    50 Citations
  • Current pharmacological approaches to the treatment of tendinopathy.

    Rocco Aicale;Rocco Domenico Bisaccia;Antonio Oliviero;Francesco Oliva

    (2020)
    47 Citations
  • The role of pharmacotherapy in the treatment of endometriosis across the lifespan

    Kaia Schwartz;Natalia C Llarena;Jenna M Rehmer;Elliott G Richards

    (2020)
    46 Citations
  • GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy

    (2023)
    43 Citations

Related Online Degrees & Career Pathways

Pursuing a career in medicine offers a wide range of related educational paths and opportunities. For those interested in advanced nursing roles, exploring the cheapest online nursing phd programs can provide an affordable route to leadership positions in healthcare.

Another essential area connected to the medical field is health information management. Students can benefit from research on the medical billing and coding schools online, which prepare graduates for critical roles in managing healthcare data and insurance processes.

For those with a background in biology, the degree opens many doors beyond clinical work. Careers with strong earning potential are highlighted in the overview of biology major jobs, ranging from research to environmental consulting and biotechnology.

Additionally, obtaining certifications like the CPC or CCS can significantly affect career growth and salary in medical coding. Understanding the differences, costs, and benefits is key, as detailed in the guide comparing ccs vs cpc certifications.

Best Scientists Contributing to This Journal

Recently Published Articles